Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
UTMD 
Utah Medical Products Inc (UTMD)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
06/27/2025: UTMD (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $
1 Year Target Price $
| 0 | Strong Buy |
| 0 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -28.47% | Avg. Invested days 26 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 06/27/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 187.75M USD | Price to earnings Ratio 15.25 | 1Y Target Price - |
Price to earnings Ratio 15.25 | 1Y Target Price - | ||
Volume (30-day avg) - | Beta 0.28 | 52 Weeks Range 50.98 - 75.79 | Updated Date 06/29/2025 |
52 Weeks Range 50.98 - 75.79 | Updated Date 06/29/2025 | ||
Dividends yield (FY) 2.11% | Basic EPS (TTM) 3.79 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 33% | Operating Margin (TTM) 35.71% |
Management Effectiveness
Return on Assets (TTM) 7.06% | Return on Equity (TTM) 10.59% |
Valuation
Trailing PE 15.25 | Forward PE - | Enterprise Value 104398199 | Price to Sales(TTM) 4.78 |
Enterprise Value 104398199 | Price to Sales(TTM) 4.78 | ||
Enterprise Value to Revenue 2.66 | Enterprise Value to EBITDA 6.82 | Shares Outstanding 3248210 | Shares Floating 2801744 |
Shares Outstanding 3248210 | Shares Floating 2801744 | ||
Percent Insiders 7.04 | Percent Institutions 70.75 |
Analyst Ratings
Rating - | Target Price - | Buy - | Strong Buy - |
Buy - | Strong Buy - | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Utah Medical Products Inc
Company Overview
History and Background
Utah Medical Products, Inc. was founded in 1978. Initially focused on developing and manufacturing specialized medical devices for women's healthcare, it has grown through internal development and acquisitions, focusing on niche markets within the broader medical device industry.
Core Business Areas
- Obstetrics & Gynecology: Utah Medical develops, manufactures, and markets a range of disposable medical devices for use in obstetrics and gynecology. These include products for labor and delivery, fetal monitoring, and cervical cancer screening.
- Electrophysiology: Devices include percutaneous cardiac ablation and diagnostic catheters, and steerable introducers to introduce such devices into the human body.
- Neonatal Intensive Care: Devices for neonatal use, including blood pressure sensors and other monitoring devices.
Leadership and Structure
The leadership team consists of Kevin Cornwell (President & CEO) and other key executives. The company operates with a relatively lean organizational structure, focusing on operational efficiency and innovation.
Top Products and Market Share
Key Offerings
- LEEP/LLETZ Products: Products used for loop electrosurgical excision procedure (LEEP) and large loop excision of the transformation zone (LLETZ) for cervical cancer screening and treatment. Market share data is difficult to pinpoint exactly, but the company holds a significant position within its niche. Competitors include CooperSurgical and Hologic (HOLX).
- Fetal Monitoring Catheters: Disposable catheters for monitoring fetal heart rate and uterine contractions during labor. Market share is moderate, with competition from major medical device companies. Competitors include Philips Healthcare and GE Healthcare (GE).
- Blood Pressure Monitoring Devices (Neonatal): Devices for measuring blood pressure in neonates in the NICU. Market share is focused within the niche, though overall revenue for UMPI is difficult to separate for this product. Competitors include Medtronic (MDT) and Baxter International (BAX).
Market Dynamics
Industry Overview
The medical device industry is characterized by innovation, regulatory scrutiny, and intense competition. Trends include minimally invasive procedures, personalized medicine, and the increasing use of technology in healthcare.
Positioning
Utah Medical Products occupies a niche position, focusing on specialized products within the OB/GYN and neonatal care segments. Its competitive advantages include a strong reputation for quality, established relationships with healthcare providers, and a focus on innovation.
Total Addressable Market (TAM)
The global medical device market is estimated to be over $500 billion. Utah Medical Products, with its specific product focus, targets a smaller segment of this overall TAM. Their TAM is likely in the several billion dollar range, with UMPI holding a very small percentage.
Upturn SWOT Analysis
Strengths
- Strong brand reputation within niche markets
- Focus on specialized, high-margin products
- Established relationships with healthcare providers
- Lean and efficient operations
- History of profitability
Weaknesses
- Limited scale compared to larger competitors
- Reliance on a small number of key products
- Vulnerability to changes in reimbursement policies
- Susceptible to economic downturns
- Dependence on single-source suppliers
Opportunities
- Expanding into new geographic markets
- Developing innovative products to address unmet needs
- Acquiring complementary businesses
- Leveraging telemedicine and remote monitoring technologies
- Growing market for minimally invasive procedures
Threats
- Intense competition from larger medical device companies
- Increasing regulatory scrutiny and compliance costs
- Pricing pressures from healthcare providers and payers
- Product liability claims
- Disruptive technologies that could render existing products obsolete
Competitors and Market Share
Key Competitors
- COOP
- HOLX
- MDT
- BAX
Competitive Landscape
Utah Medical Products competes primarily on quality, innovation, and customer service. Its smaller size can be a disadvantage against larger, more diversified competitors.
Major Acquisitions
Neonatal Products Company
- Year: 2010
- Acquisition Price (USD millions): 1.7
- Strategic Rationale: Expanded UMPI's product portfolio in the neonatal intensive care segment.
Growth Trajectory and Initiatives
Historical Growth: Historical growth has been steady but not explosive, driven by niche market dominance and strategic acquisitions.
Future Projections: Projections require analyst estimates and are subject to change. Future growth is likely to depend on successful product development and expansion into new markets.
Recent Initiatives: Recent initiatives may include product launches, acquisitions, or strategic partnerships.
Summary
Utah Medical Products is a well-established medical device company with a strong position in niche markets. Its focus on specialized products and operational efficiency has contributed to its consistent profitability. The company's smaller size and reliance on a limited number of products present some vulnerabilities. Growth opportunities exist through product development, market expansion, and strategic acquisitions. They should closely monitor competition and adapt to changing reimbursement policies.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company website
- SEC filings
- Market research reports
- Analyst reports
Disclaimers:
This analysis is for informational purposes only and should not be considered financial advice. Data may be incomplete or subject to change.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Utah Medical Products Inc
Exchange NASDAQ | Headquaters Midvale, UT, United States | ||
IPO Launch date 1999-03-08 | Chairman, CEO, President & Secretary Mr. Kevin L. Cornwell | ||
Sector Healthcare | Industry Medical Instruments & Supplies | Full time employees 155 | Website https://www.utahmed.com |
Full time employees 155 | Website https://www.utahmed.com | ||
Utah Medical Products, Inc. provides medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. The company also provides GESCO, an umbilical vessel catheter, including DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATH\NUTRI-LOK feeding device; PICC-NATE, a percutaneous intraepithelial central venous catheter; MYELO-NATE lumbar sampling kits; HEMO-NATE disposable filters; and catheterization procedure tray of instruments and supplies. In addition, it offers LETZ system to excise cervical intraepithelial neoplasia and other lower genital tract lesions; loop, ball, and needle electrodes; FILTRESSE evacuators; other specialty electrodes and supplies and gynecologic tools; Femcare trocars, cannulae, laparoscopic instruments, and accessories; and EPITOME and OptiMicro electrosurgical devices. Further, the company provides Filshie Clip female surgical contraception devices; PATHFINDER PLUS, an endoscopic irrigation device; suprapubic catheterization products; LIBERTY, a urinary incontinence treatment and control system; ENDOCURETTE, a curette for uterine endometrial tissue sampling; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other abnormalities of uterus; and LUMIN, a tool to manipulate the uterus in laparoscopic procedures. Additionally, it offers DELTRAN, a disposable pressure transducer; high-pressure and piezo-resistive transducer assemblies; and pressure monitoring accessories, components, and other molded parts. The company serves neonatal intensive care units, labor and delivery departments, women's health centers in hospitals, outpatient clinics, and physician's offices. The company was incorporated in 1978 and is headquartered in Midvale, Utah.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.